A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis (ADorable-2)

The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to 18 years of age with moderate-to-severe atopic dermatitis.

Enter your city or zip code to find the nearest site

See if You May Qualify

Answer a few questions to see if you meet key criteria for this study.

Trial Summary

Age Range
6 months - 18 years
Conditions the trial is for
Atopic Dermatitis (Eczema)
What the trial is testing?
Could I receive a Placebo?
Enrollment Goal
Trial Dates
Mar 9, 2023 - Jun 2026
How long will I be in the trial?
The study will last about 62 weeks and may include up to 13 visits.
Trial Phase

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Have received treatment from study J2T-MC-KGBI

  • Have completed study treatment from study J2T-MC-KGBI

Participants Must Not:

  • Have developed a serious adverse event from participation in study J2T-MC-KGBI

  • Have developed an adverse event from participation in study J2T-MC-KGBI

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Take the Next Step

Complete this Lilly Trial Connect questionnaire to find out if this clinical trial may be a good fit for you, or a loved one.
When you press Start Lilly Trial Connect, you will answer questions about relevant medical conditions and treatment history. The answers will be compared to some of the key criteria for this trial, called inclusion and exclusion criteria.

If your responses show that the trial may be a good fit, you can:
  • Select which clinical trial site works best for you.
  • Share your details and questionnaire directly with site(s) that allow this.
  • Get contact details for the site(s) of your choice.

Completing the Trial Connect questionnaire doesn’t mean that you will be enrolled in a study. There may be more eligibility criteria for the study which are assessed by the Lilly clinical team.

Clinical Trial Resources